Skip to content
FIND A HEALTH VALLEY ACTOR

ten23 health® and BD Partner to Advance Portable Injection Solutions

ten23health

ten23 health® has announced a strategic manufacturing partnership with BD to support the commercialization of the BD Libertas™ Wearable Injector, a ready-to-use platform designed for the subcutaneous delivery of high-volume biologic drugs. This collaboration responds to the growing demand for self-administered therapies by offering biopharmaceutical companies a fully integrated solution, combining BD’s injector technology with…

Read More

TERAPET Announces Partnership With Anzai Medical in Japan 

Terapet OK

This collaboration represents an important milestone in TERAPET’s international growth strategy and reinforces the company’s mission to make particle therapy safer, smarter, and more adaptive through imaging-driven verification. Anzai Medical Co., Ltd., a leading provider of advanced medical technologies in Japan. Under this agreement, Anzai Medical will serve as Geneva-based medtech company TERAPET’s exclusive distributor in Japan, supporting the introduction and adoption of TERAPET’s flagship platform Qualyscan® in clinical particle therapy workflows at leading centers of excellence nationwide.  This collaboration represents an important milestone in TERAPET’s international growth strategy and reinforces the…

Read More

Acrotec appoints Didier Deltort as CEO

Acrotec

Microtech and Medtech company, Acrotec Group, has an new CEO. François Billig, CEO of the Acrotec Group (“Acrotec” or the “Group”), becomes non-executive Chairman. Didier Deltort, the new CEO, brings extensive international management experience in the fast-growing medical technology and additive manufacturing sectors as the Group enters a new phase of its development. Acrotec, a…

Read More

Vi Partners announces first close of its new CHF 150 million fund

Vi Partners

The first close coincides with the 25th anniversary of Vi Partners, marking a quarter-century of continuous venture capital activity. Since its founding in 2001, Vi Partners has supported successive generations of entrepreneurs and contributed to the development of Switzerland as a leading hub for technology and healthcare innovation.  Building on more than two decades of…

Read More

4 New FIT Tech Grants To Life Sciences Projects

Obstetrical Care Solutions

Four projects have received support from the Foundation for Innovation and Technology (FIT) in the form of CHF 100’000 Tech Grants: PreciMune and Tamaro Bioscience from CHUV, and Germion Therapeutics and Obstetrical Care Solutions from EPFL will be able to continue developing their technologies with the backing of the Foundation. PreciMune delivers superior immune profiling…

Read More

Neurosoft Bioelectronics Shines at CES Las Vegas

Neurosoft BioElectronics CES Las Vegas 2026

Swiss neurotechnology startup Neurosoft Bioelectronics made a remarkable impression during CES 2026 in Las Vegas, capturing two major international awards and showcasing the global potential of next-generation brain–computer interfaces. At the Swisstech Deep Tech Pitch Battle, co-founder Ludovic Serex won 1st Prize in the AI Vertical, earning a $3,000 award and standing out among cutting-edge…

Read More

FluoSphera secures CHF 1.15 million to advance animal-free drug discovery

FluoSphera

University of Geneva spinoff FluoSphera announces a CHF 1.15 million in funding to make drug discovery faster, safer, and more human-relevant with its patented multi-tissue platform.  The round was led by Soulmates Ventures and a Swiss business angel, with participation from IndieBio New York. The startup will use the funding to scale commercial collaborations, grow its…

Read More